The p38α mitogen-activated protein kinase as a central nervous system drug discovery target
<p>Abstract</p> <p>Protein kinases are critical modulators of a variety of cellular signal transduction pathways, and abnormal phosphorylation events can be a cause or contributor to disease progression in a variety of disorders. This has led to the emergence of protein kinases as...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-12-01
|
| Series: | BMC Neuroscience |
| _version_ | 1811245220328636416 |
|---|---|
| author | Van Eldik Linda J de Almeida Lucia Borders Aaron S Watterson D Martin |
| author_facet | Van Eldik Linda J de Almeida Lucia Borders Aaron S Watterson D Martin |
| author_sort | Van Eldik Linda J |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Protein kinases are critical modulators of a variety of cellular signal transduction pathways, and abnormal phosphorylation events can be a cause or contributor to disease progression in a variety of disorders. This has led to the emergence of protein kinases as an important new class of drug targets for small molecule therapeutics. A serine/threonine protein kinase, p38α mitogen-activated protein kinase (MAPK), is an established therapeutic target for peripheral inflammatory disorders because of its critical role in regulation of proinflammatory cytokine production. There is increasing evidence that p38α MAPK is also an important regulator of proinflammatory cytokine levels in the central nervous system, raising the possibility that the kinase may be a drug discovery target for central nervous system disorders where cytokine overproduction contributes to disease progression. Development of bioavailable, central nervous system-penetrant p38α MAPK inhibitors provides the required foundation for drug discovery campaigns targeting p38α MAPK in neurodegenerative disorders.</p> |
| first_indexed | 2024-04-12T14:36:38Z |
| format | Article |
| id | doaj.art-e97da5ba6d9d413dbb00cbb7f55a9ca4 |
| institution | Directory Open Access Journal |
| issn | 1471-2202 |
| language | English |
| last_indexed | 2024-04-12T14:36:38Z |
| publishDate | 2008-12-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Neuroscience |
| spelling | doaj.art-e97da5ba6d9d413dbb00cbb7f55a9ca42022-12-22T03:29:04ZengBMCBMC Neuroscience1471-22022008-12-019Suppl 2S1210.1186/1471-2202-9-S2-S12The p38α mitogen-activated protein kinase as a central nervous system drug discovery targetVan Eldik Linda Jde Almeida LuciaBorders Aaron SWatterson D Martin<p>Abstract</p> <p>Protein kinases are critical modulators of a variety of cellular signal transduction pathways, and abnormal phosphorylation events can be a cause or contributor to disease progression in a variety of disorders. This has led to the emergence of protein kinases as an important new class of drug targets for small molecule therapeutics. A serine/threonine protein kinase, p38α mitogen-activated protein kinase (MAPK), is an established therapeutic target for peripheral inflammatory disorders because of its critical role in regulation of proinflammatory cytokine production. There is increasing evidence that p38α MAPK is also an important regulator of proinflammatory cytokine levels in the central nervous system, raising the possibility that the kinase may be a drug discovery target for central nervous system disorders where cytokine overproduction contributes to disease progression. Development of bioavailable, central nervous system-penetrant p38α MAPK inhibitors provides the required foundation for drug discovery campaigns targeting p38α MAPK in neurodegenerative disorders.</p> |
| spellingShingle | Van Eldik Linda J de Almeida Lucia Borders Aaron S Watterson D Martin The p38α mitogen-activated protein kinase as a central nervous system drug discovery target BMC Neuroscience |
| title | The p38α mitogen-activated protein kinase as a central nervous system drug discovery target |
| title_full | The p38α mitogen-activated protein kinase as a central nervous system drug discovery target |
| title_fullStr | The p38α mitogen-activated protein kinase as a central nervous system drug discovery target |
| title_full_unstemmed | The p38α mitogen-activated protein kinase as a central nervous system drug discovery target |
| title_short | The p38α mitogen-activated protein kinase as a central nervous system drug discovery target |
| title_sort | p38α mitogen activated protein kinase as a central nervous system drug discovery target |
| work_keys_str_mv | AT vaneldiklindaj thep38amitogenactivatedproteinkinaseasacentralnervoussystemdrugdiscoverytarget AT dealmeidalucia thep38amitogenactivatedproteinkinaseasacentralnervoussystemdrugdiscoverytarget AT bordersaarons thep38amitogenactivatedproteinkinaseasacentralnervoussystemdrugdiscoverytarget AT wattersondmartin thep38amitogenactivatedproteinkinaseasacentralnervoussystemdrugdiscoverytarget AT vaneldiklindaj p38amitogenactivatedproteinkinaseasacentralnervoussystemdrugdiscoverytarget AT dealmeidalucia p38amitogenactivatedproteinkinaseasacentralnervoussystemdrugdiscoverytarget AT bordersaarons p38amitogenactivatedproteinkinaseasacentralnervoussystemdrugdiscoverytarget AT wattersondmartin p38amitogenactivatedproteinkinaseasacentralnervoussystemdrugdiscoverytarget |